SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples

Overview of attention for article published in Clinical Epigenetics, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 32,663 followers.

RT @StoverLab: Great talk from @JoshLangMD & George Zhao @UWCarbone: "Next generation liquid biopsies for solid tumor clinical trials" as p…

RT @StoverLab: Great talk from @JoshLangMD & George Zhao @UWCarbone: "Next generation liquid biopsies for solid tumor clinical trials" as p…

Great talk from @JoshLangMD & George Zhao @UWCarbone: "Next generation liquid biopsies for solid tumor clinical trials" as part of @BigTenCRC Grand Rounds. Great work - including cutting edge approaches like SEEMLIS https://t.co/64jmjuT3pa https://t.c

RT @OAgenetics: SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples https://t.co/B3UyjLozr6 T…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.